hengrui glp-1 Hengrui, Kailera's oral clears late-stage bar in China but US results still pending GSK forges $12bn alliance with

Metformin is now increasingly being used in combination with new incretin-based therapies: glucagon-like peptide 1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors [46], both of which enhance pancreatic beta cell function

Further studies and well-controlled clinical trials should be conducted in this context to develop the most reliable anti-diabetic agents screened from mushroom polysaccharides

Acknowledgments We acknowledge the use of OpenAIs ChatGPT (version: GPT-4, model: gpt-4-turbo) for language editing and refinement of the manuscript

They are often related to dehydration, reduced caloric intake, or caffeine withdrawal if coffee consumption decreases alongside overall food intake